Crescendo Bioscience

by in

Entry	Author	Date	Location
Crescendo Bioscience Snags $28M For Arthritis Test	Luke Timmerman	01/03/13	San Francisco
Crescendo Bioscience Garners $28,000,000 Series D Financing Round	VentureDeal	01/03/13	San Francisco
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy	Luke Timmerman	09/08/11	San Francisco
Crescendo Bioscience Obtains $25,000,000 New Funding Round	VentureDeal	09/08/11	San Francisco
Crescendo Bioscience Secures $31,000,000 Series C Round	VentureDeal	09/08/11	San Francisco
Crescendo Bioscience Lands $31,019,775 Series C Financing	VentureDeal	06/20/11	San Francisco
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News	Luke Timmerman	02/11/11	San Francisco
Diagnostics Are Warming Up in Era of Fast, Cheap Sequencing, Says MDV’s Rowan Chapman	Luke Timmerman	02/07/11	San Francisco
Crescendo Bioscience Secures $37,600,004 New Funding	VentureDeal	07/07/10	San Francisco
Crescendo Bioscience Lands $5,000,000 Series B Round	VentureDeal	11/30/09	San Francisco
Crescendo Bioscience Garners $15,000,000 New Funding	VentureDeal	06/30/08	San Francisco
Page 1 of 1

Xconomy National